Differentiation Of Canine Bone Marrow Mesenchymal  Stem Cells Into Islet–Like Cells

P M Deepa; Umesh Dimri; Vikas Chandra; G Taru Sharma

doi:10.48165/

Authors

P M Deepa Department of Veterinary Epidemiology and Preventive Medicine, College of Veterinary and Animal Sciences, Kerala Veterinary and Animal Sciences University, Pookode, Wayanad - 673 576, Kerala (India)
Umesh Dimri Division of Medicine, Indian Veterinary Research Institute, Izatnagar, Bareilly – 243122, Uttar Pradesh (India)
Vikas Chandra Division of Physiology and Climatology, Indian Veterinary Research Institute, Izatnagar, Bareilly – 243122, Uttar Pradesh (India)
G Taru Sharma Division of Physiology and Climatology, Indian Veterinary Research Institute, Izatnagar, Bareilly – 243122, Uttar Pradesh (India)

DOI:

https://doi.org/10.48165/

Keywords:

BMSCs, differentiation, dogs, islet-like cells

Abstract

The present study was aimed to study in vitro differentiation of canine bone marrow mesenchymal stem cells (BMSCs) to islet-like cells of pancreas. BMSCs were isolated from healthy dogs and cultured in laboratory. BMSCs after 3rd passage (at 80% confluence) were induced to differentiate into islet like cells by using 2-step induction methods.Characterization of differentiated cells of BMSC into islet-like cells was done by observing cell morphology, expression of canine insulin gene by reverse transcriptase PCR (RT-PCR) and quantitative PCR (qPCR), detection of nestin and insulin proteins by immunocytochemistry and quantification of insulin level in culture media. Typical grape-like clusters of cells were observed under bright field microscope. Expression of insulin gene and protein was observed in differentiated cells. Insulin level in culture media of differentiated cells was significantly high. It was concluded that canine BMSCs could effectively be differentiated into islet-like cells. These differentiated cells could play an important role in diabetic therapy of dogs.

Downloads

Download data is not yet available.

References

Cao, L.Z., Tang, D.Q., Horb, M.E., Li, S.W. and Yang, L.J. 2004. High glucose is necessary for complete maturation of Pdx-1-VP16-expressing hepatic cells into functional insulin producing cells. Diabetes, 53: 3168-3178.

Caplan, A.I. and Dennis, J.E. 2006. Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98: 1076-1084.

Cernea, S., Buzzetti, R. and Pozzilli, P. 2009. β-cell protection and therapy for latent autoimmune diabetes in adults. Diabetes Care, 32: 246-252.

Chen, L.B., Jiang, X.B. and Yang, L. 2004. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta cells. World Journal of Gastroenterology, 10: 3016-3020.

Chelluri, L.K., Kancheria, R., Turiapati, N., Vemuri, S., Debnath, T., Kumar, M.P., Beevi, S.S. and Kamaraju, R.S. 2011. Improved differentiation protocol of rat bone marrow precursors to functional islet like cells. Stem Cell Studies, 1: e5. (DOI: https://doi.org/10.4081/scs.2011.e5)

Cook, C.S., Valaitis, P.W., Brugger, A., Heise, T., Gass, J., Anderson, L., Troeger, J., White, S., Eckers, U., Nosek, L., Rave, K and Heinemann, L. 2011. Difference in relative bioavailability of inhalation insulin determined using insulin and glucose levels following subcutaneous and inhalation administration in humans. Journal of Bioequivalence & Bioavailability, 3: 198-201.

Flynn, J. and Priestly, M. 2014. Mesenchymal stem cells in clinical practice. pp. 365-383. In: Stem Cells in Aesthetic Procedures (eds. M.A. Shiffman, A. Di Guiseppe and F. Bassetto). Springer, Berlin, Germany.

Kim, H.S. and Lee, M.K. 2016. β-cell regeneration through the trans-differentiation of pancreatic cells: Pancreatic progenitor cellsin the pancreas. Journal of Diabetes Investigation, 7: 286-296. Livak, K.J. and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real time quantitative PCR and the 2-ΔΔCT method. Methods, 25: 402-408.

Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y. and Wang, Y. 2014. Immunobiology of mesenchymal stem cells. Cell Death and Differentiation, 21: 216-225.

Mabed, M. and Shahin, M. 2012. Mesenchymal stem cell-based therapy for treatment of type 1 diabetes mellitus. Current Stem Cell Research and Therapy, 7: 179-190.

Reaven, G. 2012. Insulin resistance and coronary heart disease in nondiabetic individuals. Arteriosclerosis, Thrombosis and Vascular Biology, 32: 1754-1759.

Sheng, G. 2015. The developmental basis of mesenchymal stem/stromal cells. BMC Developmental Biology, 15: 44.

Si, Y., Zhao, Y., Hao, H., Liu, J., Guo, Y., Mu, Y., Shen, J., Cheng, Y., Fu, X. and Han, W. 2012. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: Identification of a novel role in improving insulin sensitivity. Diabetes, 61: 1616-1625.

Takemitsu, H., Zhao, D., Yamamoto, I., Harada, Y., Michishita, M. and Arai, T. 2012. Comparison of bone marrow and adipose tissue derived canine mesenchymal stem cells. BMC Veterinary Research, 31: 150.

Takemitsu, H., Zhao, D., Ishikawa, S., Michishita, M., Arai, T. and Yamamoto, I. 2013. Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells. General and Comparative Endocrinology, 189: 1-6.

Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y. and Deng, H. 2009. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Research, 19: 429-438.

Zhao, Y., Jiang, Z., Zhao, T., Ye, M., Hu, C., Yin, Z., Li, H., Zhang, Y., Diao, Y., Li, Y., Chen, Y., Sun, X., Fisk, M.B., Skidgel, R., Hollerman, M., Prabhakar, B. and Mazzone, T. 2012. Reversal of type1 diabetes via islet β cell regeneration following immune modulation by cord blood derived multipotent stem cells. BMC Medicine, 10: 3.

Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K. and Habener, J.F. 2001. Multipotent nestin positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. Diabetes, 50: 521-533.